Emerging Theranostic Targets in Squamous Cell Carcinoma of the Head and Neck [0.03%]
头颈部鳞状细胞癌中新兴的诊疗靶点
Sophie C Siegmund,Sebastian E Serfling,Takahiro Higuchi et al.
Sophie C Siegmund et al.
This review aims to explore the evolving field of theranostics in oncology, focusing on its potential application to head and neck squamous cell carcinoma (HNSCC). Specifically, it examines the integration of molecular imaging and radionucl...
Radioactive Gold Isotopes in the Era of Theranostics: Medical Potential of ¹⁹⁸Au and ¹⁹⁹Au Radioisotopes [0.03%]
放射诊疗时代具有诊断和治疗潜力的198Au和199Au放射性同位素的研究进展
Punita Bhardwaj,Guilhem Claude,Winfried Brenner et al.
Punita Bhardwaj et al.
Radioactive gold isotopes, particularly the element-matched theranostic pair 198Au and 199Au, hold significant promise for targeted radionuclide therapy and SPECT imaging. This review critically evaluates their medical potential by contextu...
177Lu-based radioligand therapy: A retrospective multicenter analysis to calculate the effective half-life and follow-up dose for the public [0.03%]
基于177Lu的放射配体治疗：一项回顾性多中心分析，用于计算有效半衰期和公众随访剂量
Christian Schütze,Markus Borowski,Martin Freesmeyer et al.
Christian Schütze et al.
The study investigated routinely used radiopharmaceuticals containing lutetium-177 (177Lu), providing reference values for their effective half-life (T1/2,eff). So far, no guidelines regarding discharging this patients exist, are essential ...
Oliver Lindner,Christian Goetz,Frank M Bengel et al.
Oliver Lindner et al.
This updated position paper from the German Society of Nuclear Medicine (DGN) and the German Cardiac Society (DGK) replaces the original statement from 2018. It gives an overview of the fields of application and the current value of nuclear...
Primary Tumor Localization is Associated with Progression-free Survival and Overall Survival after Selective-Internal-Radio-Therapy of Liver Metastases in Metastatic Colorectal Cancer [0.03%]
选择性体内放射治疗转移性结直肠癌肝转移时原发灶的定位与无进展生存期和总生存期相关
Lucia Lutat,Barbara Kreppel,Milka Marinova et al.
Lucia Lutat et al.
This retrospective study aimed to investigate whether the differing biology of right-sided primary tumors (RSP) and left-sided primary tumors (LSP) in metastatic colorectal cancer (mCRC) affects survival outcomes following selective interna...
Prognostic Significance of CD68+ Macrophages and FoxP3+ Regulatory T Cells in Neuroendocrine Tumors [0.03%]
神经内分泌肿瘤中CD68+巨噬细胞和FoxP3+调节性T细胞的预后意义
Barbara Kreppel,Jana Fink,Christine Sanders et al.
Barbara Kreppel et al.
Neuroendocrine tumors (NETs) are a heterogeneous group of malignancies characterized by variable immune microenvironment. This study aimed to analyze the infiltration of NETs by CD68+ tumor-associated macrophages (TAMs) and FoxP3+ regulator...
Diagnosis of hepatic alveolar echinococcosis:18F-FDG-PET activity compared to the Echinococcus multilocularis Ulm Ultrasound Classification [0.03%]
肝泡状棘球蚴病的诊断：18F-FDG-PET活性与Echinococcus multilocularis Ulm超声分类相比
Wolfgang Kratzer,Sibylle Steinkellner,Dennis Skotnik et al.
Wolfgang Kratzer et al.
Alveolar echinococcosis (AE) is a rare, potentially fatal zoonosis with highly heterogeneous morphology. This study compares AE lesions in B-scan ultrasound, categorized according to the Echinococcus multilocularis Ulm Classification - Ultr...
Imaging-based characterization of tumoral heterogeneity for personalized cancer treatment [0.03%]
基于影像的肿瘤异质性表征的个性化癌症治疗研究进展
Florian Haag,Alexander Hertel,Hishan Tharmaseelan et al.
Florian Haag et al.
With personalized tumor therapy, understanding and addressing the heterogeneity of malignant tumors is becoming increasingly important. Heterogeneity can be found within one lesion (intralesional) and between several tumor lesions emerging ...
Interventional Radiology in the Era of Radiotheranostics: An Update for Interventional Radiologists! [0.03%]
放射治疗时代的意义介入放射学：介入放射学家的最新研究！
Islam A S Elhelf,Michael Clemenshaw
Islam A S Elhelf
In 2018, the Food and Drug Administration (FDA) approved lutetium-177 (177Lu) DOTATATE (LUTATHERA, Advanced Accelerator Applications [Novartis]) for the treatment of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumor...
Experimental approach for optimizing dose regimen of 68Ga-DOTATATE PET/CT for neuroendocrine tumor (NET) imaging in current high sensitivity scanners: Phantom and Patient Study [0.03%]
用于神经内分泌肿瘤显像的68Ga-DOTATATE PET/CT注射剂量优化实验方法：体模及临床研究
Abbas Monsef,Fatemeh Saboktakin,Fatemeh Sadeghi et al.
Abbas Monsef et al.
This study aimed to determine the optimized scan time and injected activity regimen for clinical 68Ga DOTATATE PET/CT in neuroendocrine tumor imaging through an experimental approach without using machine learning techniques.A NEMA PET body...